ERAS
Closed
Erasca Inc
1.36
+0.09 (+7.09%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.27
Day's Range: 1.235 - 1.375
Send
sign up or login to leave a comment!
When Written:
3.01
Erasca Inc is a biotechnology company focused on developing precision therapies for cancer. The company was founded in 2018 and is based in San Diego, California. Erasca's mission is to "erase cancer" by developing therapies that target the underlying genetic drivers of tumors. The company is led by a team of experienced biotech executives and has partnerships with leading academic institutions and pharmaceutical companies. Erasca is backed by top-tier investors, including ARCH Venture Partners, City Hill Ventures, Cormorant Asset Management, and Invus Opportunities. The company's pipeline includes several promising drug candidates in various stages of development, including ERAS-007, which is currently in Phase 1 clinical trials for the treatment of solid tumors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








